2.66
Anixa Biosciences Inc (ANIX) 最新ニュース
Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties - BioSpace
Anixa Biosciences (ANIX) to Release Earnings on Tuesday - Defense World
Anixa Biosciences to Present at the 18th Annual European Life Sc - GuruFocus.com
Anixa Biosciences : to Hold Conference Call to Discuss Outlook for 2019 -January 16, 2019 at 07:31 am EST - Marketscreener.com
Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th - PR Newswire
Spotlight On February 2025's Promising Penny Stocks - Yahoo Finance
Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial - PR Newswire
Can Anixa's Ovarian Cancer CAR-T Therapy Advance After Successful 10-Fold Dose Escalation? - StockTitan
Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox New - GuruFocus.com
Can This Breast Cancer Vaccine Change Prevention Forever? Anixa's Trial Shows 70% Response Rate - StockTitan
Anixa Biosciences Featured in Breaking Cancer News Article on No - GuruFocus.com
Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer - PR Newswire
HC Wainwright Issues Optimistic Forecast for ANIX Earnings - Defense World
Is Agenus (AGEN) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
HC Wainwright Reaffirms “Buy” Rating for Anixa Biosciences (NASDAQ:ANIX) - Armenian Reporter
Anixa Biosciences’ (ANIX) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Anixa Biosciences Announces Approval of Protocol Amendment for O - GuruFocus.com
Anixa Biosciences expands CAR-T therapy trial for ovarian cancer - Investing.com
Anixa Biosciences expands CAR-T therapy trial for ovarian cancer By Investing.com - Investing.com South Africa
Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial - PR Newswire
Major Breakthrough: Anixa's Ovarian Cancer Trial ExpandsSecond CAR-T Dose Now Available for Patients - StockTitan
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock - MSN
Anixa Biosciences director Lewis H. Titterton Jr. buys $15,540 in stock - MSN
Short Interest in Anixa Biosciences, Inc. (NASDAQ:ANIX) Expands By 13.7% - MarketBeat
Revolutionary Cancer Treatment Alert: Anixa's Dual-Attack Strategy Against Ovarian and Breast Cancer Unveiled - StockTitan
Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview - PR Newswire
Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum - sharewise
Anixa Biosciences Inc (ANIX) Stock: A Closer Look at the Market Potential - The News Heater
Contrasting Eterna Therapeutics (NASDAQ:ERNA) and Anixa Biosciences (NASDAQ:ANIX) - Defense World
Breakthrough Cancer Prevention: Anixa CEO Reveals Novel Vaccine Strategy Against Triple-Negative Breast Cancer - StockTitan
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention - PR Newswire
Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases 5,000 Shares of Stock - MarketBeat
Anixa biosciences director Arnold Baskies buys $14,100 in stock - MSN
Insider Buying: Arnold Baskies Acquires Additional Shares of Ani - GuruFocus.com
Anixa biosciences director Arnold Baskies buys $14,100 in stock By Investing.com - Investing.com UK
Anixa Biosciences director Titterton buys $8,820 in common stock - MSN
Anixa Biosciences director Titterton buys $8,820 in common stock By Investing.com - Investing.com Australia
Anixa Biosciences’ (ANIX) Buy Rating Reiterated at D. Boral Capital - Defense World
Anixa Biosciences reports progress in cancer vaccine trials - MSN
Anixa Biosciences director Lewis Titterton buys $6,020 worth of stock By Investing.com - Investing.com Australia
Insider Buying: Titterton Lewis H jr Acquires Additional Shares of Anixa Biosciences Inc (ANIX) - GuruFocus.com
Anixa Biosciences, Inc. (NASDAQ:ANIX) Director Purchases $15,540.00 in Stock - MarketBeat
大文字化:
|
ボリューム (24 時間):